Finding high-quality online pharmacology CME for PAs is a recurring necessity for maintaining national certification and state licensure. Pharmacology requirements are often specific and stringent, particularly for those with prescriptive authority. Understanding the nuances of accreditation, credit weighting, and content relevance is essential for an efficient educational experience.
Below are the logistical details for our primary pharmacology offering:
The most critical factor when selecting an online course is verifying its accreditation status. To satisfy NCCPA and state board requirements, the activity must be formally reviewed and approved. Our Pharmacology CME Review Package has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. It is designated for 12 AAPA Category 1 Self-Assessment CME credits. PAs must ensure the certificate explicitly states the credit type and the AAPA reference number (e.g., CME-209464) to avoid issues during an audit.
Not all Category 1 credits are weighted equally by the NCCPA. Self-assessment activities are specifically designed to provide an active learning experience. For NCCPA certification maintenance purposes, the NCCPA applies an additional 50 percent weighting to these credits. When you log the 12 credits earned from our pharmacology course, they automatically count as 18 credits toward your 100-hour cycle requirement. This makes self-assessment pharmacology courses one of the most time-efficient ways to manage your CME.
While the NCCPA does not mandate a specific number of pharmacology hours, many state medical boards do. For example, states like Maryland and Ohio require a minimum number of pharmacology-focused Category 1 hours for license renewal. These requirements often link directly to your ability to maintain prescriptive authority and DEA registration. Our course content focuses on drug mechanisms, indications, dosing, and adverse effects, specifically to help practitioners meet these state-level mandates.
While our content is written by physician assistants for physician assistants, other healthcare providers find significant value in these packages.
Pharmacology is not a monolithic subject. It must be applied across various clinical environments. Our pharmacology review covers essential prescribing principles across nine core specialties: Emergency Medicine, Family Medicine, Internal Medicine, Orthopedics, Dermatology, Psychiatry, Neurology, Cardiology, and OB/GYN. This breadth ensures that whether you work in a surgical subspecialty or primary care, the pharmacological principles remain relevant to your daily practice.
Many PAs receive an annual CME stipend that must be used within a specific fiscal year. June is the final month to use many CME stipends, so if your funds expire mid-year or on June 30, this is the time to use them. If you still have professional development money available, consider applying it to our Pharmacology CME Review Package before June 30 so you can secure 12 AAPA Category 1 Self-Assessment CME credits, a 120-question pharmacology bank, and extended access for ongoing review. To help clinicians further enrich their education, we also offer CME with Amazon and Apple Gift Card add-ons. You can add a gift card ranging from $100 to $1500 to your purchase. The total cost is included in the package price, allowing you to utilize your professional development funds effectively. Please note that gift card packages are non-refundable once the card has been processed and emailed.
Passive learning through reading or watching videos is often insufficient for long-term retention of complex pharmacological data. Our course includes a 120-question bank. These questions are designed to simulate real-world clinical scenarios, forcing the learner to apply basic science and pharmacologic principles to patient care. Each question includes a detailed explanation of the correct answer and why the distractors are incorrect.
Clinical schedules are unpredictable. An effective online pharmacology course must be accessible on-demand. Our courses provide 30 months of access, allowing you to complete the 120 questions and the associated lectures at your own pace. This duration is particularly beneficial for PAs who wish to revisit specific modules as clinical questions arise in their practice.
Peer-to-peer education often provides more practical, "in-the-trenches" insight than purely academic courses. Our content is developed by experienced Physician Assistants who understand the specific challenges of the PA profession, including the nuances of the NCCPA Blueprint and the practicalities of clinical practice. This ensures the medical terminology and abbreviations (e.g., HR, SaO2, PID) are used fluently and in the correct clinical context.
It is essential to distinguish between specialized pharmacology courses and comprehensive exam review courses. While the Pharmacology CME Review provides 12 hours of Category 1 credit, our PANRE Review Course provides 100 hours of AAPA Category 1 credit. If you are preparing for the traditional PANRE or the PANRE-LA, the 100-hour course offers a more comprehensive review of the entire NCCPA Blueprint, whereas the pharmacology course is a targeted tool for prescribing requirements.
The following scenarios are designed to test your clinical application of pharmacological principles.
Your patient is a 64-year-old male with a history of hypertension and chronic kidney disease (Stage 3). He presents with an acute gouty flare in his left first metatarsophalangeal joint. His current medications include lisinopril and hydrochlorothiazide. His serum creatinine is 2.1 mg/dL (baseline 1.9 mg/dL). Which of the following is the most appropriate first-line treatment for his acute gout flare?
A. Indomethacin
B. Naproxen
C. Prednisone
D. Allopurinol
Explanation: Prednisone is the correct choice because the patient has Stage 3 chronic kidney disease (CKD). NSAIDs, such as indomethacin and naproxen, are contraindicated or should be used with extreme caution in patients with significant renal impairment due to the risk of further decreasing the glomerular filtration rate (GFR). Allopurinol is used for urate-lowering therapy in the maintenance phase of gout, not for the treatment of an acute flare. In patients with CKD, systemic or intra-articular corticosteroids are the preferred first-line agents for acute inflammation.
Your patient is a 28-year-old female who is currently 10 weeks pregnant. She presents to the clinic with symptoms of a urinary tract infection, including dysuria and frequency. A urine culture is pending, but a dipstick is positive for nitrites and leukocyte esterase. She has no known drug allergies. Which of the following antibiotics should be avoided in this patient?
A. Ciprofloxacin
B. Nitrofurantoin
C. Cephalexin
D. Amoxicillin
Explanation: Ciprofloxacin should be avoided. Fluoroquinolones are generally contraindicated in pregnancy due to potential risks to fetal cartilage development. Cephalexin and Amoxicillin are Category B and generally considered safe. Nitrofurantoin is also commonly used in the first trimester but should be avoided near term (38-42 weeks) due to the risk of neonatal hemolysis. In this scenario, a fluoroquinolone is the most appropriate answer to exclude.
Your patient is a 55-year-old male with a history of permanent atrial fibrillation and a CHADS2-VASc score of 3. He is currently taking dabigatran for stroke prevention. He is scheduled for an elective inguinal hernia repair. According to standard clinical guidelines, when should dabigatran be discontinued prior to a procedure with a standard risk of bleeding, assuming a normal GFR?
A. 12 hours prior
B. 24 hours prior
C. 72 hours prior
D. 5 days prior
Explanation: 24 hours prior is the standard recommendation for a patient with normal renal function (CrCl > 50 mL/min) undergoing a procedure with a standard risk of bleeding. Dabigatran has a relatively short half-life compared to warfarin (which requires 5 days for discontinuation). If the procedure carried a high risk of bleeding or if the patient had significant renal impairment, the discontinuation window would be extended to 48-72 hours. 12 hours is insufficient to ensure adequate clearance of the anticoagulant effect.
Your patient is a 45-year-old female with a history of depression who is currently taking phenelzine (an MAOI). She presents with a severe headache, palpitations, and a blood pressure of 190/110 mmHg. She mentions she attended a wine and cheese party earlier this evening. This clinical presentation is most likely due to an interaction with which substance?
A. Tryptophan
B. Tyramine
C. Phenylalanine
D. Gluten
Explanation: Tyramine is the correct answer. MAOIs (Monoamine Oxidase Inhibitors) like phenelzine prevent the breakdown of tyramine, which is found in aged cheeses, red wine, and cured meats. High levels of tyramine cause a massive release of norepinephrine, leading to a hypertensive crisis, characterized by severe headache, tachycardia, and significantly elevated blood pressure. Tryptophan and phenylalanine do not cause this specific "cheese effect" hypertensive reaction.
Your patient is a 67-year-old male with systolic heart failure and chronic atrial fibrillation. His medications include furosemide, lisinopril, metoprolol, and digoxin. He presents with nausea, yellow-tinted vision, and intermittent confusion. HR is 48, BP 102/64, and ECG shows frequent premature ventricular contractions. Which of the following is the most likely cause of his presentation?
A. Beta-blocker toxicity
B. Hypercalcemia
C. Digoxin toxicity
D. Serotonin syndrome
Explanation: Digoxin toxicity is the correct answer. The combination of nausea, visual disturbances, bradycardia, confusion, and ventricular ectopy is classic. In real practice, you would check a digoxin level, renal function, and potassium because reduced clearance and electrolyte abnormalities commonly precipitate toxicity. Beta-blocker toxicity can cause bradycardia, but it does not typically cause yellow vision. Hypercalcemia and serotonin syndrome do not fit this clinical picture.
Selecting an online pharmacology CME for PAs requires a focus on accreditation, NCCPA weighting, and the inclusion of high-quality assessment tools. June is the final month to use many CME stipends, and if your funds expire on June 30, this pharmacology review is a practical way to use them before the deadline. By choosing a course that offers AAPA Category 1 pharmacology credit and incorporates practical clinical vignettes, PAs can fulfill their regulatory requirements while enhancing their clinical competency.
Course: PANRE Review CoursePrice: $499.00 (Base Course)Duration: 12-Month AccessDeliverables: 100 Hours of AAPA Category 1…
PAEA added Growth & Development as a new 10% content area on the Pediatrics EOR…
Navigating the world of Continuing Medical Education (CME) can be frustrating when your credentials don't…
Pharmacology Review CME Package: $399.99Access Duration: 30 MonthsDeliverables: 12 AAPA Category 1 Pharmacology Credits, 120+…
Course: PANRE Review Course & Pharmacology CourseCredits: 100 Hours of AAPA Category 1 Credit (PANRE…
Course Specifications and Logistics Price: $399.99 (Base Package) Duration of Access: 30 Months Deliverables: 100…